منابع مشابه
To Biopsy a Small Renal Mass, or Not?
Please cite this paper as: Chatzidarellis E, Skolarikos A, Papatsoris AG. To Biopsy a Small Renal Mass or Not? Nephro-Urol Mon. 2012;4(2): 423-4. DOI: 10.5812/numonthly.3991 Implication for health policy/practice/research/medical education: As abdominal imaging has increased the diagnosis of small renal masses (SRMs) the role of renal mass biopsy (RMB) is debatable. Current literature demonstra...
متن کاملConcerns about renal mass biopsy.
I read with great interest the case report by Abourbih and colleagues.1 In few last decades, the diagnosis of small renal masses (SRMs) has increased due to the routine use of imaging modalities.2 Small renal masses represent 48% to 66% of all renal cell carcinomas and only 1% of them will spread to distant metastasis.3 There is a need to biopsy SRMs to distinguish their behavior by radiologic ...
متن کاملThe contemporary role of renal mass biopsy in the management of small renal tumors
The selective use of percutaneous biopsy for diagnosis in renal masses is a relatively uncommon approach when compared to the management of other solid neoplasms. With recent advancements in imaging techniques and their widespread use, the incidental discovery of asymptomatic, small renal masses (SRM) is on the rise and a substantial percentage of these SRM are benign. Recent advances in diagno...
متن کاملCurrent Status of Renal Biopsy for Small Renal Masses
Small renal masses (SRMs) are defined as radiologically enhancing renal masses of less than 4 cm in maximal diameter. The incidence of renal cell carcinoma (RCC) has increased in recent years, which is mainly due to the rise in incidental detection of localized SRMs. However, the cancer-specific mortality rate is not increasing. This discrepancy may be dependent on the indolent nature of SRMs. ...
متن کاملImproving needle biopsy accuracy in small renal mass using tumor-specific DNA methylation markers
PURPOSE The clinical management of small renal masses (SRMs) is challenging since the current methods for distinguishing between benign masses and malignant renal cell carcinomas (RCCs) are frequently inaccurate or inconclusive. In addition, renal cancer subtypes also have different treatments and outcomes. High false negative rates increase the risk of cancer progression and indeterminate diag...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
nephro-urology monthlyجلد ۴، شماره ۲، صفحات ۴۲۳-۴۲۴
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023